St John's wort greatly reduces the concentrations of oral oxycodone

European Journal of Pain : EJP
Tuija H NieminenK T Olkkola

Abstract

Chronic pain is associated with depression. Self-treatment of depression with herbal over-the-counter medicine St John's wort makes pain patients prone to drug interactions. The aim of this study was to assess the potential of St John's wort to alter the CYP3A-mediated metabolism of a mu-opioid receptor agonist, oxycodone. The study design was placebo-controlled, randomized, cross-over with two phases at intervals of 4 weeks and was conducted with 12 healthy participants. St John's wort (Jarsin) or placebo was administered t.i.d. for 15 days and oral oxycodone hydrochloride 15 mg on day 14. Oxycodone pharmacokinetics and pharmacodynamics were compared after St John's wort or placebo. Behavioural and analgesic effects were assessed with subjective visual analogue scales and cold pressor test. Plasma drug concentrations were measured from 0 to 48 h, behavioural and analgesic effects from 0 to 12 h. Following St John's wort administration the oxycodone AUC decreased 50% (p<0.001). Oxycodone elimination half-life shortened from a mean+/-SD 3.8+/-0.7 to 3.0+/-0.4h (p<0.001). The self-reported drug effect of oxycodone as measured by AUEC(0-12) decreased significantly (p=0.004). Differences between St John's wort and placebo phases in...Continue Reading

References

Oct 1, 1991·British Journal of Clinical Pharmacology·R PöyhiäE Kalso
Jul 18, 1970·British Medical Journal·J G Hannington-Kiff
Jan 1, 1984·British Journal of Clinical Pharmacology·B M Stone
Jan 1, 1996·Clinical Pharmacology and Therapeutics·R F KaikoP D Goldenheim
Jul 21, 1998·JAMA : the Journal of the American Medical Association·O GurejeR Gater
Jan 1, 1999·Clinical Pharmacology and Therapeutics·T HeiskanenE Kalso
Jun 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·L B MooreS A Kliewer
Feb 7, 2001·The American Journal of Psychiatry·R C KesslerD M Eisenberg
Feb 17, 2001·Clinical Pharmacology and Therapeutics·D DürrK Fattinger
Aug 7, 2001·Journal of the American Pharmaceutical Association : APhA·M WurglicsM Schubert-Zsilavecz
Dec 26, 2001·Clinical Pharmacology and Therapeutics·K SugimotoA Fujimura
Feb 19, 2002·British Journal of Clinical Pharmacology·Martina HennessyJ Feely
Jan 25, 2003·Clinical Pharmacology and Therapeutics·George K DresserRichard B Kim
Mar 22, 2003·Pharmacopsychiatry·D Eich-HöchliC B Eap
Sep 18, 2003·JAMA : the Journal of the American Medical Association·John S MarkowitzKenneth D Chavin
Nov 12, 2003·Archives of Internal Medicine·Matthew J BairKurt Kroenke
Nov 13, 2003·JAMA : the Journal of the American Medical Association·Pekka T MäntyselkäEsko A Kumpusalo
Dec 10, 2003·Clinical Pharmacology and Therapeutics·Evan D KharaschPam Sheffels
Mar 25, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bojan LalovicDanny D Shen
Sep 1, 2004·Journal of Pain and Symptom Management·Edward MichnaRobert N Jamison
Oct 8, 2004·Clinical Pharmacology and Therapeutics·Ingrid MaiIvar Roots
Oct 27, 2004·Anesthesia and Analgesia·Joseph Gimbel, Harry Ahdieh
Nov 13, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Paul SloanHarry Ahdieh
May 21, 2005·Clinical Chemistry·Johanna SistonenAntti Sajantila
Jul 9, 2005·Clinical Pharmacology and Therapeutics·Jens RengelshausenGerd Mikus
Aug 13, 2005·European Journal of Pain : EJP·Harald BreivikDerek Gallacher
Dec 1, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Eric Prommer
Dec 13, 2005·European Journal of Clinical Pharmacology·Silke C MuellerBernd Drewelow
Feb 16, 2006·European Journal of Clinical Pharmacology·Rajanikanth MadabushiVeronika Butterweck
Oct 3, 2006·British Journal of Clinical Pharmacology·D L WhittenH Wohlmuth
Jun 27, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Ute Gödtel-ArmbrustLeszek Wojnowski
Feb 26, 2008·British Journal of Clinical Pharmacology·Hiromitsu ImaiKyoichi Ohashi
Sep 3, 2008·European Journal of Clinical Pharmacology·Silke C MuellerBernd Drewelow
Dec 19, 2008·European Journal of Pain : EJP·Katri HamunenEija Kalso
Mar 4, 2009·Clinical Orthopaedics and Related Research·Jacquelyn MarshDianne Bryant
May 7, 2009·Anesthesiology·Tuija H NieminenKlaus T Olkkola

❮ Previous
Next ❯

Citations

Dec 12, 2012·Pharmacogenomics and Personalized Medicine·Pascal H VuilleumierRuth Landau
Mar 8, 2013·Trends in Pharmacological Sciences·Klaus T OlkkolaEija A Kalso
Nov 28, 2014·Chinese Journal of Integrative Medicine·Tony Yuqi TangJanyne Afseth
Mar 16, 2013·Expert Opinion on Drug Metabolism & Toxicology·Romina KlimasGerd Mikus
Oct 5, 2010·Pharmacological Reports : PR·Wojciech Leppert
Jun 4, 2011·Fundamental & Clinical Pharmacology·Marko A PeltoniemiKlaus T Olkkola
Jul 31, 2013·Phytotherapy Research : PTR·Emilio RussoGiovambattista De Sarro
Apr 15, 2015·Journal of Analytical Toxicology·David E MoodyWenfang B Fang
Jul 3, 2013·The Journal of the American Dental Association·Mark Donaldson, Riva Touger-Decker
Apr 16, 2014·Complementary Therapies in Medicine·Eran Ben-AryeElad Schiff
Jul 28, 2016·Frontiers in Plant Science·Ana I OliveiraAlberto C P Dias
Oct 4, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stéphane MoulyJ-F Bergmann
Jul 22, 2016·Der Schmerz·H Petri, D Grandt
May 4, 2018·British Journal of Pharmacology·Jannis E MeentsAngelika Lampert
Sep 18, 2018·Pharmacogenetics and Genomics·Rachel HuddartTeri E Klein
Feb 8, 2018·The Journal of Pharmacy and Pharmacology·Sigrun Chrubasik-HausmannAndrew J McLachlan
Feb 27, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hazem E HassanNatalie D Eddington
Jan 12, 2020·Biopharmaceutics & Drug Disposition·Jaana RytkönenAki T Heikkinen
Apr 29, 2018·Journal of Food and Drug Analysis·Manuela Grimstein, Shiew-Mei Huang
Sep 7, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anne Leuppi-TaegtmeyerStephan Krähenbühl
Sep 9, 2017·Expert Opinion on Drug Metabolism & Toxicology·Samaneh SoleymaniMohammad Abdollahi
Jun 3, 2018·European Journal of Drug Metabolism and Pharmacokinetics·Lilian W KibathiParag Kumar
Jan 18, 2019·Clinical Pharmacokinetics·Mari KinnunenMerja Kokki
Mar 7, 2021·Pharmaceutics·Behdad JahromiNebojsa Nick Knezevic
Aug 27, 2021·Medicines·Mary Beth BabosPaul Herscu
Nov 14, 2020·Complementary Therapies in Medicine·J K RoydhouseP G Kluetz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.